Lipoproteins inhibit macrophage activation by lipoteichoic acid

Journal of Lipid Research

Volumn 40, Issue 2, 1999, Pages 245-252

  Grunfeld, Carl ^a,b   Marshall, Maureen ^a,b   Shigenaga, Judy K ^a,b   Moser, Arthur H ^a,b   Tobias, Peter ^c   Feingold, Kenneth R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Infection; Lipopolysaccharide; Lipoproteins; Lipoteichoic acid; Tumor necrosis factor

Indexed keywords

BINDING PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPOLYSACCHARIDE; LIPOPROTEIN; LIPOTEICHOIC ACID; LOW DENSITY LIPOPROTEIN; SOYBEAN OIL; TUMOR NECROSIS FACTOR; ANTIBODY; CARRIER PROTEIN; TEICHOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; INFECTION; LIPID METABOLISM; MACROPHAGE; MACROPHAGE MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BLOOD; CELL CULTURE; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MACROPHAGE ACTIVATION; METABOLISM; PHYSIOLOGY; SECRETION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIBODIES; CARRIER PROTEINS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; SOYBEAN OIL; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032962088     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Beisal, W. R. 1975. Metabolic responses to infection. Annu. Rev. Med. 26: 9-20.
2. Hardardottir, I., C. Grunfeld, and K. R. Feingold. 1994. Effects of endotoxin and cytokines on lipid metabolism. Curr. Opin. Lipidol. 5: 207-215.
3. Richards, C., and J. Gauldie. 1995. Role of cytokines in acute phase response. In Human Cytokines: Their Role in Disease and Therapy. B. B. Aggarwal, and R. K. Puri, editors. Blackwell Science, Cambridge. 253-269.
4. Grunfeld, C., and K. R. Feingold. 1992. Tumor necrosis factor, interleukin and interferon induced changes in lipid metabolism as part of host defense. Proc. Soc. Exp. Biol. Med. 200: 224-227.
5. Levin J., T. E. Poore, N. P. Zauber, and R. S. Oser. 1970. Detection of endotoxin in the blood of patients with sepsis due to gram-negative organisms. N. Engl. J. Med. 238: 1313-1316.
6. Elin, R. J., and S. M. Wolff. 1976. Biology of endotoxin. Annu. Rev. Med. 27: 127-141.
7. Feingold, K. R., I. Staprans, R. A. Memon, A. H. Moser, J. K. Shigenaga, W. Doerrler, C. A. Dinarello, and C. Grunfeld. 1992. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J. Lipid Res. 33: 1765-1776.
8. Ulevitch, R. J., A. R. Johnston, and D. B. Weinstein. 1979. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides. J. Clin. Invest. 64: 1516-1524.
9. Freudenberg, M. A., T. C. Bog-Hansen, U. Back, and C. Galanos. 1980. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect. Immun. 28: 373-380.
10. Munford, R. S., C. I., Hall, and J. M. Dietschy. 1981. Binding of Salmonella typhimurium lipopolysaccharides to rat high density lipoproteins. Infect. Immun. 34: 835-843.
11. Ulevitch, R. J., A. R. Johnson, and D. B. Weinstein. 1981. New function for high density lipoproteins: isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J. Clin. Invest. 67: 827-837.
12. Munford, R. S., C. L. Hall, J. M. Lipton, and J. M. Dietschy. 1982. Biological activity, lipoprotein binding behavior and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J. Clin. Invest. 70: 877-888.
13. Van Lenten, B. J., A. M. Fogelman, M. E. Haberland, and P. A. Edwards. 1986. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 83: 2704-2708.
14. Flegel, W. A., A. Wolpl, D. N. Mannel, and H. Northoff. 1989. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect. Immun. 57: 2237-2245.
15. Cavaillon, J. M., C. Fitting, N. H. Cavaillon, S. J. Kirsch, and H. S. Warren. 1990. Cytokine response by monocyte and macrophage to free and lipoprotein-bound lipopolysaccharide. Infect. Immun. 58: 2375-2382.
16. Flegel, W. A., M. W. Baumstark, C. Weinstock, A. Berg, and H. Northoff. 1993. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect. Immun. 61: 5140-5146.
17. Weinstock, C., H. Ulrich, R. Hohe, A. Berg, M. W. Baumstark, I. Frey, H. Northoff, and W. A. Flegel. 1992. Low density lipoproteins inhibit endotoxin activation of monocytes. Arterioscler. Thromb. 12: 341-347.
18. Harris, H. W., C. Grunfeld, K. R. Feingold, and J. H. Rapp. 1990. Human VLDL and chylomicrons can protect against endotoxin-induced death in mice. J. Clin. Invest. 86: 696-702.
19. Harris, H. W., C. Grunfeld, K. R. Feingold, T. E. Read, J. P. Kane, A. L. Jones, E. B. Eichbaum, G. F. Bland, and J. H. Rapp. 1993. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J. Clin. Invest. 91: 1028-1034.
20. Feingold, K. R., J. L. Funk, A. H. Moser, J. K. Shigenaga, J. H. Rapp, and C. Grunfeld. 1995. Role for circulating lipoproteins in the protection from endotoxin toxicity. Infect. Immun. 63: 2041-2046.
21. Levine, D. M., T. S. Parker, T. M. Donnelly, A. Walsh, and A. L. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA. 57: 2237-2245.
22. Hubsch, A. P., F. S. Powell, P. G. Lerch, and J. E. Doran. 1993. A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. Circ. Shock. 40: 14-23.
23. Cue, J. I., J. T. DiPiro, L. J. Brunner, J. E. Doran, M. E. Blankenship, A. R. Mansberger, and M. L. Hawkins. 1994. Reconstituted high density lipoprotein inhibits physiologic and tumor necrosis factor a responses to lipopolysaccharide in rabbits. Arch. Surg. 129: 193-197.
24. Read, T. E., C. Grunfeld, Z. L. Kumwenda, M. C. Calhoun, K. R. Feingold, and J. H. Rapp. 1995. Triglyceride-rich lipoproteins improve survival when given after endotoxin in rats. Surgery. 117: 62-67.
25. Read, T. E., C. Grunfeld, Z. L. Kumwenda, M. C. Calhoun, J. P. Kane, K. R. Feingold, and J. H. Rapp. 1995. Triglyceride-rich lipoproteins prevent septic death in rats. J. Exp. Med. 182: 267-272.
26. Leong, J. C., J. P. Kane, O. Oleszko, and L. A. Levy. 1977. Antigen specific non-immunoglobulin factor that neutralizes xenotropic virus is associated with mouse serum lipoproteins. Proc. Natl. Acad. Sci. USA. 74: 276-280.
27. Seganti, L., M. Grassi, P. Matromarino, A. Pana, F. Superti, and N. Orsi. 1983. Activity of human serum lipoproteins on the infectivity of rhabdoviruses. Microbiology. 6: 91-99.
28. Sernatinger, J., A. Hoffman, D. Harmon, J. P. Kane, and J. A. Levy. 1988. Neutralization of mouse xenotropic virus by lipoproteins involves binding to virons. J. Gen. Virol. 69: 2651-2661.
29. Heumer, H. P., H. J. Menzel, D. Potratz, B. Brake, D. Falke, G. Utermann, and M. P. Dierich. 1988. Herpes simplex virus binds to human serum lipoproteins. Intevirology. 29: 68-76.
30. Shortridge, K. R., W. K. Ho, A. Oya, and M. Kobayashi. 1975. Studies on the inhibitory activities of human serum lipoproteins for Japanese encephalitis virus. SE Asian J. Trop. Med. Public Health. 6: 461-466.
31. Rifkin, M. R. 1978. Identification of the trypanocidal factor in normal human serum: high density lipoproteins. Proc. Natl. Acad. Sci. USA. 75: 3450-3454.
32. Hajduk, S. L., D. R. Moore, J. Vasudevacharya, H. Siqueira, A. F. Torri, E. M. Tytler, and J. D. Esko. 1989. Lysis of Trypanosoma bruceii by a toxic subspecies of human high density lipoprotein. J. Biol. Chem. 264: 5210-5217.
33. Gillett, M. P., and J. S. Owen. 1991. Trypanosoma brucei brucei: differences in the trypanocidal activity of human plasma and its relationship to the level of high density lipoproteins. Trans. R. Soc. Trop. Med. Hygiene. 85: 612-616.
34. Natanson, C., R. L. Danner, R. J. Elin, J. M. Hosseini, K. W. Peart, S. M. Banks, T. J. MacVittie, R. I. Walker, and J. E. Parrillo. 1989. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococus aureas challenges in a canine model of human septic shock. J. Clin. Invest. 83: 243-251.
35. Wakabayashi, G., J. A. Gelfand, W. K. Jung, R. J. Connolly, J. F. Burke, and C. A. Dinarello. 1991. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia: comparison to Escherichia coli. J. Clin. Invest. 87: 1925-1935.
36. Aiura, K., J. A. Gelfand, J. F. Burke, R. C. Thompson, and C. A. Dinarello. 1993. Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1β in rabbits. Infect. Immun. 61: 3342-3350.
37. Christensen, G. D., A. L. Bisno, J. T. Parisi, B. McLaughlin, M. G. Hester, and R. W. Luther. 1982. Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Ann. Intern. Med. 96: 1-10.
38. Burchard, K. W., L. B. Minor, G. J. Slotman, and D. S. Gann. 1984. Staphylococcus epidermidis sepsis in surgical patients. Arch. Surg. 119: 96-100.
39. McLean, L. D., W. G. Mulligan, A. P. McLean, and J. H. Duff. 1967. Patterns of septic shock in man: a detail study of 56 patients. Ann. Surg. 166: 543-562.
40. Farshtchi, D., and V. J. Lewis. 1968. Effects of three bacterial infections on serum lipids of rabbits. J. Bacteriol. 95: 1615-1621.
41. Fisher, R. H., J. C. Denniston, and W. R. Beisel. 1972. Infection with Diplococcus pneumoniae and Salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins. J. Infect. Dis. 125: 54-60.
42. Alvarez, C., and A. Ramos. 1986. Lipids, lipoproteins and apoproteins in serum during infection. Clin. Chem. 32: 142-145.
43. Fisher, R. H., J. C. Denniston, R. B. Rindsing, and W. R. Beisel. 1971. Effects of acute infection on cholesterogenesis in the rhesus monkey. Proc. Soc. Exp. Biol. Med. 138: 605-609.
44. Canonico, P. G., E. Ayala, W. L. Rill, and J. S. Little. 1977. Effects of pneumococcal infection on rat liver microsomal enzymes and lipogenesis by isolated hepatocytes. Am. J. Clin. Nutr. 30: 1359-1363.
45. Mcraihi, Z., O. Lutz, J. M. Scheftel, A. Frey, and C. Bach. 1990. Gram-positive bacterial sepsis in rat and tissue lipolytic activity on commercial parenteral fat emulsion. Infection. 18: 109-112.
46. Wicken, A. J., and K. W. Knox. 1975. Lipoteichoic acids: a new class of bacterial antigen. Membrane lipoteichoic acids can function as surface antigens of gram-positive bacteria. Science. 187: 1161-1167.
47. Wicken, A. J., and K. W. Knox. 1980. Bacterial cell surface amphiphiles. Biochim. Biophys. Acta. 604: 1-26.
48. Bhakdi, S., T. Klonisch, P. Nuber, and W. Fischer. 1991. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 59: 4614-4620.
49. Keller, R., W. Fisher, R. Keist, and S. Bassetti. 1992. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect. Immun. 60: 3664-3672.
50. Standiford, T. J., D. A. Arenberg, J. M. Danforth, S. L. Kunkel, G. M. Vanotteren, and R. M. Strierter. 1994. Lipoteichoic acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infect. Immun. 62: 119-125.
51. De Kimpe, S. J., M. Kengatharan, C. Thiemermann, and J. R. Vane. 1995. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. USA. 92: 10359-10363.
52. Nonogaki, K., A. H. Moser, X-M. Pan, I. Staprans, C. Grunfeld, and K. R. Feingold. 1995. Lipoteichoic acid stimulates lipolysis and hepatic triglyceride secretion in rats in vivo. J. Lipid Res. 36: 1987-1995.
53. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide-binding protein. Science. 249: 1429-1431.
54. Harlow, E., and D. Lane. 1988. Antibodies: a Laboratory Manual. Cold Spring Harbor Press, Cold Spring Harbor, NY.
55. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
56. Espevik, T., and J. Nissen-Meger. 1986. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods. 95: 99-105.
57. Tobias, P. S., K. Soldau, and R. J. Ulevitch. 1989. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide-binding protein. J. Biol. Chem. 264: 10867-10871.
58. Mathison, J. C., P. S. Tobias, E. Wolfson, and R. J. Ulevitch. 1992. Plasma lipopolysaccharide (LPS)-binding protein: a key component in macrophage recognition of gram-negative LPS. J. Immunol. 149: 200-206.
59. Gallay, P., C. Barras, P. S. Tobias, T. Calandra, M. P. Glauser, and D. Heumann. 1994. Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS. J. Infect. Dis. 170: 1319-1322.
60. Calvano, S. E., W. A. Thompson, M. N. Marra, S. M. Coyle, H. F. de Riesthal, R. K. Trousdale, P. S. Barie, R. W. Scott, L. L. Moldawer, and S. F. Lowry. 1994. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide-binding protein during endotoxemia or sepsis. Arch. Surg. 129: 220-226.
61. Grunfeld, C., R. A. Memon, J. H. Rapp, and K. R. Feingold. 1992. Regulation of hepatic lipid metabolism by cytokines that induce the acute phase response. Folia Histochem. Cytobiol. 30: 201-202.
62. Shephard, E. G., R. Anderson, A. F. Strachan, S. H. Kuhn, and F. C. DeBeer. 1986. CRP and neutrophils: functional effects and complex uptake. Clin. Exp. Immunol. 63: 718-727.
63. Mookerjea, S., J. Francis, D. Hunt, C. Y. Yang, and A. Nagpurkar. 1994. Rat C-reactive protein causes a charge modification of LDL and stimulates its degradation by macrophages. Arterioscler. Thromb. 14: 282-287.
64. DeBeer, F. C., A. K. Soutar, M. L. Baltz, I. M. Traynor, A. Feingold, and M. B. Pepys. 1982. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J. Exp. Med. 156: 230-242.
65. Pajkrt, D., J. E. Doran, F. Koster, P. G. Lerch, B. Arnet, T. van der Poll, J. W. ten Cate, and S. J. van Deventer. 1996. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J. Exp. Med. 184: 1601-1608.
66. Pajkrt, D., P. G. Lerch, T. van der Poll, M. Levi, M. Illi, J. E. Doran, B. Arnet, A. van den Ende, J. W. ten Cate, and S. J. van Deventer. 1997. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia. Thromb. Haemost. 77: 303-307.
67. Wurfel, M. M., S. T. Kunitake, H. Lichenstein J. P. Kane, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J. Exp. Med. 180: 1025-1035.
68. Rensen, P. C. N., M. van Oosten, E. van de Bilt, M. van Eck, J. Kuiper, and T. J. C. van Berkel. 1997. Lipoproteins: are they important components of host defense? J. Clin. Invest. 99: 2438-2445.
69. Xu, X., and J. P. Caulfield. 1992. Characterization of human low density lipoprotein binding proteins on the surface of schistosomula of Schistosoma mansoni. Eur. J. Cell Biol. 57: 229-235.
70. Xu, X., H. G. Remold, and J. P. Caulfield. 1993. Potential role for scavenger receptors of human monocytes in the killing of Schistosoma mansoni. Am. J. Pathol. 142: 685-689.
71. Jacobs, D., A. Blackburn, M. Higgins, D. Reed, H. Iso, G. McMillan, J. Neaton, J. Nelson, J. Potter, B. Rifkind, et al. 1992. Report of the conference on low blood cholesterol: mortality associations. Circulation. 86: 1046-1060.
72. Claxton, A. J., D. R. Jacobs, C. Iribarren, S. L. Welles, S. Sidney, and K. R. Feingold. 1998. The association between serum total cholesterol and HIV infection in a high risk cohort of young men. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 17: 51-57.
73. Newton, J. D., and D. N. Wentworth. Low serum cholesterol and risk of death from AIDS. AIDS. 11: 929-930.